Michele Schneider | Jan 08, 2025 12:14AM ET
In my Outlook for 2025 I list 10 picks.
But then, I end with Honorable Mention stocks that I describe as:
“These stocks faced challenges in 2024, but as we approach 2025, they show promising fundamentals and charts with clear support levels and obvious breakout points.”
Moderna (NASDAQ:MRNA) is first on that list.
Also stated in the Outlook 2025 about the ETF IBB or a member of the Economic Modern Family (Big Brother Biotechnology):
“Should IBB hold the 80-month moving average, we expect an uptrend into 2025, driven by big pharma's focus on immunology and treatments, as well as the growing popularity of diet drugs.”
Looking at the Daily chart of Moderna:
In June 1024, MRNA broke down under the 50 daily moving average. Then in August, MRNA failed the 200-DMA.
Until today, January 7th, the downtrend has been significant.
Now, with the headlines as a catalyst, MRNA cleared the 50-DMA.
We like to see a second-day confirmation of a phase change, in this case from bearish to recuperation.
Leadership is a plus and momentum agrees with the need for confirmation, rallying right into the Bollinger band.
(Pivotal means short-term bullish above that level and bearish below)
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.